Re: Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
6
|
Resverlogix Corp.
|
Sep 15, 2020 12:47PM
|
After reading today's posts....
|
5
|
Resverlogix Corp.
|
Sep 16, 2020 08:08PM
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
8
|
Resverlogix Corp.
|
Sep 19, 2020 08:35PM
|
Re: What’s the Evidence?
|
7
|
Resverlogix Corp.
|
Sep 26, 2020 08:20PM
|
Re: Rules of thumb and broken thumbs...
|
5
|
Resverlogix Corp.
|
Sep 29, 2020 06:12PM
|
Re: Nonprofit Think Tank
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 10:20PM
|
Hepalink or Ori?
|
4
|
Resverlogix Corp.
|
Oct 06, 2020 01:45PM
|
Resverlogix and Zenith AGMs.
|
7
|
Resverlogix Corp.
|
Oct 08, 2020 01:15AM
|
December 22, 2020.
|
6
|
Resverlogix Corp.
|
Oct 08, 2020 02:10PM
|
Re: December 22, 2020.
|
5
|
Resverlogix Corp.
|
Oct 09, 2020 11:57PM
|
Before the AGM cut-off.
|
6
|
Resverlogix Corp.
|
Oct 13, 2020 07:09PM
|
Re: Re San fran
|
4
|
Resverlogix Corp.
|
Oct 19, 2020 03:20PM
|
Re: Re San fran
|
9
|
Resverlogix Corp.
|
Oct 20, 2020 03:04PM
|
Re: Covid and apabetalone
|
13
|
Resverlogix Corp.
|
Oct 20, 2020 11:47PM
|
Re: Covid and apabetalone
|
9
|
Resverlogix Corp.
|
Oct 21, 2020 12:04AM
|
Re: Covid and apabetalone
|
7
|
Resverlogix Corp.
|
Oct 21, 2020 12:26AM
|
Neuropilin-1 is a host factor for SARS-CoV-2 infection.
|
3
|
Resverlogix Corp.
|
Oct 21, 2020 12:06PM
|
Bayer and the CKD space we wanted to dominate in.
|
3
|
Resverlogix Corp.
|
Oct 25, 2020 02:17AM
|
Scientists warn of new coronavirus variant spreading across Europe.
|
2
|
Resverlogix Corp.
|
Oct 30, 2020 01:29AM
|
Re: Hepa / ORI
|
1
|
Resverlogix Corp.
|
Oct 30, 2020 11:53PM
|